Can fluorescence-guided surgery improve optimal surgical treatment for ovarian cancer? A systematic scoping review of clinical studies
Open Access
- 27 January 2023
- journal article
- review article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 33 (4) , 549-561
Abstract
Background The predicament of achieving optimal surgical intervention faced by surgeons in treating ovarian cancer has driven research into improving intra-operative detection of cancer using fluorescent materials. Objective To provide a literature overview on the clinical use of intra-operative fluorescence-guided surgery for ovarian cancer, either for cytoreductive surgery or sentinel lymph node (SLN) biopsy. Methods The systematic review included studies from June 2002 until October 2021 from PubMed, Web of Science, and Scopus as well as those from a search of related literature. Studies were included if they investigated the use of fluorescence-guided surgery in patients with a diagnosis of ovarian cancer. Authors charted variables related to study characteristics, patient demographics, baseline clinical characteristics, fluorescence-guided surgery material, and treatment details, and surgical, oncological, and survival outcome variables. After screening 2817 potential studies, 24 studies were included. Results Studies investigating the role of fluorescence-guided surgery to visualize tumor deposits or SLN biopsy included the data of 410 and 118 patients, respectively. Six studies used indocyanine green tracer with a mean SLN detection rate of 92.3% with a pelvic and para-aortic detection rate of 94.8% and 96.7%, respectively. The sensitivity, specificity, and positive predictive value for micrometastases detection of OTL38 and 5-aminolevulinc acid at time of cytoreduction were 92.2% vs 79.8%, 67.3% vs 94.8%, and 55.8% vs 95.8%, respectively. Conclusion Fluorescence -guided surgery is a technique that may improve the detection rate of micrometastases and SLN identification in ovarian cancer. Further research is needed to establish whether this will lead to improved patient outcomes.Keywords
This publication has 45 references indexed in Scilit:
- Cytoreductive Surgery Under Aminolevulinic Acid-Mediated Photodynamic Diagnosis Plus Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Ovarian Cancer and Primary Peritoneal Carcinoma: Results of a Phase I TrialAnnals of Surgical Oncology, 2014
- Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody UptakeCancer Research, 2013
- Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human resultsNature Medicine, 2011
- Scoping studies: advancing the methodologyImplementation Science, 2010
- Lymph node metastasis detection of ovarian cancer by porphyrin fluorescence photodetection: case reportLasers in Medical Science, 2007
- Fluorescence staining of human ovarian cancer tissue following application of 5‐aminolevulinic acid: Fluorescence microscopy studiesLasers in Surgery and Medicine, 2006
- Scoping studies: towards a methodological frameworkInternational Journal of Social Research Methodology, 2005
- Fluorescein angiography for the detection of metastases of ovarian tumor in the abdominal cavity, a feasibility pilotLasers in Surgery and Medicine, 2004
- Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5‐aminolevulinic acid‐induced protoporphyrin IXCancer, 2004
- Feasibility Study to Detect Ovarian Cancer Micrometastases by Fluorescence PhotodetectionLasers in Medical Science, 2002